The long-term management of obesity with continuing pharmacotherapy

Obesity Research

Volumn 12, Issue 11, 2004, Pages 1821-1827

  Frank, Arthur ^a,b  

^a GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^b GEORGE WASHINGTON UNIVERSITY   (United States)

Author keywords

Long term obesity medications; Obesity medications; Obesity pharmacotherapy; Obesity treatment; Phentermine

Indexed keywords

ANOREXIGENIC AGENT; PHENTERMINE;

ADULT; AGED; ARTICLE; BODY MASS; BODY WEIGHT; CASE REPORT; FEMALE; HUMAN; MALE; MIDDLE AGED; OBESITY; TIME;

ADULT; AGED; APPETITE DEPRESSANTS; BODY MASS INDEX; BODY WEIGHT; FEMALE; HUMANS; MALE; MIDDLE AGED; OBESITY; PHENTERMINE; TIME FACTORS;

EID: 16644396862     PISSN: 10717323     EISSN: None     Source Type: Journal    
DOI: 10.1038/oby.2004.226     Document Type: Article

References (15)

1. Editor's introduction. Br Med J. 2003;3:217.
2. Glazer G. Long-term pharmacotherapy of obesity 2000. Arch Intern Med. 2001;161:1814-24.
3. Padwal R, Li SK, Lau DCW. Long-term pharmacotherapy for overweight and obesity: a systematic review and meta-analysis of randomized controlled trials. Int J Obes. 2003;27:1437-46.
4. Padwal R, Li S, Lau D. Long-term pharmacotherapy for obesity and overweight. Cochrane Database Syst Rev. 2003;4:CD004094.
5. Long-term pharmacotherapy in the management of obesity: National Task Force on the Prevention and Treatment of Obesity. JAMA. 1996;276:1907-15.
6. Weintraub M, Sundaresan PR, Schuster B, Averbuch M, Stein EC, Byrne L. Long-term weight control study: V. Weeks 190-210: follow-up of participants after cessation of medication. Clin Pharmacol Ther. 1992;51:615-8.
7. Purnell JQ. Obesity. In: Scientific American Medicine. Danbury, CT: WebMD Professional Publishing, USA; 2003.
8. Campbell ML, Mathys ML. Pharmacologic options for the treatment of obesity. Am J Health Syst Pharm. 2001;58:1301-8.
9. Fujioka K. Management of obesity as a chronic disease: nonpharmacologic, pharmacologic, and surgical options. Obes Res. 2002; 10(Suppl 2): 116-23S.
10. Atkinson RL. Use of drugs in the treatment of obesity. Annu Rev Nutr. 1997;17:383-403.
11. Bray GA. A concise review on the therapeutics of obesity. Nutrition. 2000;16:953-60.
12. Stafford RS, Radley DC. National trends in antiobesity medication use. Arch Intern Med. 2003;163:1046-50.
13. Weintraub M. Long-term weight control: the National Heart, Lung and Blood Institute funded multimodal intervention study. Clin Pharmacol Ther. 1992;51:581-646.
14. Bray GA. Use and abuse of appetite suppressant drugs in the treatment of obesity. Ann Intern Med. 1993;119:707-13.
15. Bray GA, Greenway FL. Current and potential drugs for the treatment of obesity. Endocr Rev. 1999;20:805-75.